Härkönen P - Search Results

1

Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.

Sandholm J, Lehtimäki J, Ishizu T, Velu SE, Clark J, Härkönen P, Jukkola-Vuorinen A, Schrey A, Harris KW, Tuomela JM, Selander KS. Sandholm J, et al. Among authors: harkonen p. Oncotarget. 2016 Dec 27;7(52):87373-87389. doi: 10.18632/oncotarget.13570. Oncotarget. 2016. PMID: 27888633 Free PMC article.

2

Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro.

Wärri AM, Huovinen RL, Laine AM, Martikainen PM, Härkönen PL. Wärri AM, et al. Among authors: harkonen pl. J Natl Cancer Inst. 1993 Sep 1;85(17):1412-8. doi: 10.1093/jnci/85.17.1412. J Natl Cancer Inst. 1993. PMID: 8350365

3

Calcitonin promotes osteoclast survival in vitro.

Selander KS, Härkönen PL, Valve E, Mönkkönen J, Hannuniemi R, Väänänen HK. Selander KS, et al. Among authors: harkonen pl. Mol Cell Endocrinol. 1996 Sep 18;122(2):119-29. doi: 10.1016/0303-7207(96)03870-1. Mol Cell Endocrinol. 1996. PMID: 8902842

4

Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages.

Selander KS, Mönkkönen J, Karhukorpi EK, Härkönen P, Hannuniemi R, Väänänen HK. Selander KS, et al. Among authors: harkonen p. Mol Pharmacol. 1996 Nov;50(5):1127-38. Mol Pharmacol. 1996. PMID: 8913344

5

Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.

Junttila TT, Sundvall M, Lundin M, Lundin J, Tanner M, Härkönen P, Joensuu H, Isola J, Elenius K. Junttila TT, et al. Among authors: harkonen p. Cancer Res. 2005 Feb 15;65(4):1384-93. doi: 10.1158/0008-5472.CAN-04-3150. Cancer Res. 2005. PMID: 15735025 Free article.

6

Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.

Tuomela JM, Valta MP, Väänänen K, Härkönen PL. Tuomela JM, et al. Among authors: harkonen pl. BMC Cancer. 2008 Mar 28;8:81. doi: 10.1186/1471-2407-8-81. BMC Cancer. 2008. PMID: 18371232 Free PMC article.

7

FGF-8 is involved in bone metastasis of prostate cancer.

Valta MP, Tuomela J, Bjartell A, Valve E, Väänänen HK, Härkönen P. Valta MP, et al. Among authors: harkonen p. Int J Cancer. 2008 Jul 1;123(1):22-31. doi: 10.1002/ijc.23422. Int J Cancer. 2008. PMID: 18386787 Free article.

8

Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis.

Wegiel B, Bjartell A, Tuomela J, Dizeyi N, Tinzl M, Helczynski L, Nilsson E, Otterbein LE, Härkönen P, Persson JL. Wegiel B, et al. Among authors: harkonen p. J Natl Cancer Inst. 2008 Jul 16;100(14):1022-36. doi: 10.1093/jnci/djn214. Epub 2008 Jul 8. J Natl Cancer Inst. 2008. PMID: 18612129 Free PMC article.

9

The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.

Säfholm A, Tuomela J, Rosenkvist J, Dejmek J, Härkönen P, Andersson T. Säfholm A, et al. Among authors: harkonen p. Clin Cancer Res. 2008 Oct 15;14(20):6556-63. doi: 10.1158/1078-0432.CCR-08-0711. Clin Cancer Res. 2008. PMID: 18927296 Free article.

10

FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer.

Valta MP, Tuomela J, Vuorikoski H, Loponen N, Väänänen RM, Pettersson K, Väänänen HK, Härkönen PL. Valta MP, et al. Among authors: harkonen pl. J Cell Biochem. 2009 Jul 1;107(4):769-84. doi: 10.1002/jcb.22175. J Cell Biochem. 2009. PMID: 19415685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page